IRIS Institutional Research Information System - OPENBS Open Archive UniBS

DE PETRO, Giuseppina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.888
EU - Europa 5.521
AS - Asia 2.835
SA - Sud America 29
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 21
Totale 14.343
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.819
PL - Polonia 1.459
CN - Cina 1.204
DE - Germania 1.036
UA - Ucraina 927
IT - Italia 637
SG - Singapore 595
HK - Hong Kong 435
FI - Finlandia 329
RU - Federazione Russa 261
FR - Francia 238
GB - Regno Unito 237
IN - India 202
TR - Turchia 179
IE - Irlanda 155
SE - Svezia 92
VN - Vietnam 77
CA - Canada 59
BE - Belgio 52
ID - Indonesia 48
AT - Austria 21
EU - Europa 21
AU - Australia 19
NL - Olanda 18
BR - Brasile 17
KR - Corea 15
IR - Iran 14
CZ - Repubblica Ceca 10
CH - Svizzera 9
PK - Pakistan 9
RO - Romania 8
AZ - Azerbaigian 7
MU - Mauritius 7
SD - Sudan 7
TH - Thailandia 7
MX - Messico 6
LY - Libia 5
AR - Argentina 4
ES - Italia 4
IL - Israele 4
JP - Giappone 4
LT - Lituania 4
SA - Arabia Saudita 4
BG - Bulgaria 3
DK - Danimarca 3
GR - Grecia 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MA - Marocco 3
PT - Portogallo 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CL - Cile 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EE - Estonia 2
GE - Georgia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
CR - Costa Rica 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LV - Lettonia 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
RS - Serbia 1
SI - Slovenia 1
SL - Sierra Leone 1
TJ - Tagikistan 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 14.343
Salva come PNG Salva come JPEG
Città #
Warsaw 1.456
Jacksonville 671
Fairfield 604
Woodbridge 469
Chandler 465
Singapore 439
Hong Kong 429
Ann Arbor 391
Ashburn 377
Houston 308
Wilmington 290
Princeton 288
Nanjing 264
Cambridge 262
Seattle 228
Beijing 214
Helsinki 206
Brescia 198
New York 167
Dublin 154
Dearborn 151
Istanbul 144
Nanchang 91
Moscow 72
Shenyang 71
Dong Ket 70
Jinan 68
Hebei 67
Des Moines 63
Milan 53
Changsha 52
Brussels 49
Jiaxing 49
Tianjin 47
Jakarta 46
Shanghai 46
Lancaster 42
Los Angeles 40
Kunming 39
Munich 33
Pune 32
San Diego 29
Toronto 26
Kocaeli 25
Verona 25
San Francisco 23
Hangzhou 22
Zhengzhou 22
London 18
Ningbo 18
North York 18
Nürnberg 17
Boardman 14
Lappeenranta 13
Guangzhou 12
Haikou 12
Lanzhou 12
Nuremberg 12
Redwood City 12
Romola 12
Falkenstein 11
Norwalk 11
Taizhou 11
Vienna 11
Bologna 10
Fuzhou 10
Melbourne 10
Bari 9
Hefei 9
Orange 9
Phoenix 8
Sundbyberg 8
Amsterdam 7
Botucatu 7
Magnago 7
Ottawa 7
Santa Clara 7
Taiyuan 7
Baku 6
Karachi 6
Napoli 6
Philadelphia 6
San Mateo 6
Augusta 5
Borås 5
Brno 5
Brooklyn 5
Castelnuovo Bozzente 5
Chur 5
Mexico City 5
Naples 5
Pontevico 5
Rockville 5
Suwon 5
Washington 5
Berlin 4
Changchun 4
Chicago 4
Copertino 4
Council Bluffs 4
Totale 9.816
Salva come PNG Salva come JPEG
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 320
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 283
Environment and bladder cancer: molecular analysis by interaction networks 278
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 223
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 215
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 199
Functional Role of microRNA-23b-3p in Cancer Biology 196
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 191
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 183
Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers 181
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 169
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 164
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 160
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 156
Preparazione di colture primarie di fibroblasti di embrione di pollo . 153
Biological Function of MicroRNA193a-3p in Health and Disease 146
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 146
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 145
De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay. 143
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 142
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 141
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 139
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 137
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 131
microRNAs and human hepatocellular carcinoma 130
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 127
RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma 126
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 124
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 123
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 119
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 119
Transmembrane protein TMEM230, regulator of metalloproteins and motor proteins in gliomas and gliosis 118
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 118
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 118
miRNA Editing: New Insights into the Fast Control of Gene Expression in Health and Disease 115
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 114
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 110
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 110
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 109
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 108
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 107
Transformation-enhancing activity of gelatin binding fragments of fibronectin 106
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 104
Transformation enhancing activity in plasma of tumor patients: relationship with fibronectin fragments 103
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 103
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 103
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 102
Interaction of tissue type plasminogen activator with fibronectin and fibronectin fragments 102
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 102
A rapid and highly sensitive solid phase enzyme immunoassay specific for human fibronectin using a characterized monoclonal antibody 102
Inhibition of Rous sarcoma virus-induced transformation by proteins involved in blood coagulation 101
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 100
Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts 100
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 100
Transformation enhancing activity present in the plasma of cancer patients binds to gelatin. 100
Matrix assembly induction and cell migration and invasion inhibition by a 13-amino acid fibronectin peptide 99
Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activators. 97
Evidence for preferential proteolytic cleavage of one of the two fibronectin subunits and for immunological localization of a site distinguishing them 96
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 93
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 91
Role of fibronectin degradation products on cellular transformation. 91
Studi per lo sviluppo di terapie innovative molecolari per l’epatocarcinoma cellulare: microRNA e sorafenib. 91
Characterization of a 13 aminoacid human fibronectin peptide induce matrix assembly and inhibiting migration and invasion in tumor cells 90
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 90
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 90
Tissue-type plasminogen activator but not urokinase exerts transformation enhancing activity 87
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 87
Urokinase and c-met are target of miR-23b in human cells. 85
Phosphorylation of human plasminogen activators and plasminogen. 83
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 83
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 81
RT-PCR detection of EDA+ fibronectin mRNA isoforms as hepatocarcinoma markers. 80
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 80
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 80
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 79
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 79
u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor in RNA is down regulated in human hepatocellular carcinoma 79
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 78
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 76
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 76
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 75
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 75
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 74
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 73
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 73
Androgen receptor mRNA under-expression in poorly differentiated human hepatocellular carcinoma. 73
Transformation enhancing factors in vitro and in vivo. Potential as cancer markers 72
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 72
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 71
Utilization of Rous sarcoma virus for the detection of transformation enhancing and inhibiting factors in human plasma. 71
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 71
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 71
La trascrizione in Molecole, cellule e Organismi 71
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 70
Transformation enhancing factors and fibronectin degradation products as possible tumor markers. 70
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 70
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 69
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 68
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 68
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 68
Totale 11.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.102 0 0 0 0 0 0 0 0 231 473 204 194
2020/20212.086 57 252 51 252 72 246 95 242 324 203 180 112
2021/20221.186 62 215 56 73 10 41 49 68 67 127 130 288
2022/20231.248 186 64 35 123 119 296 13 104 187 10 48 63
2023/20241.308 95 31 137 75 63 274 83 46 233 53 28 190
2024/20251.792 41 64 66 462 326 306 283 119 125 0 0 0
Totale 14.693